Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL EXECUTIVE YUAN R O C	TAOYUAN CITY 32546

International Classification(s)

• G01N:INVESTIGATING OR ANALYSING MATERIALS BY DETERMININ....

• 2013 Application Filing Year
• G01N Class
• 9056 Applications Filed
• 7640 Patents Issued To-Date
• 84.37 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Chen, Chun-Ying	Taoyuan County, TW	79	743
# of filed Patents : 79 Total Citations : 743
Chen, Kuan-Yin	Taoyuan County, TW	13	40
# of filed Patents : 13 Total Citations : 40
Fu, Meng-Jun	Taoyuan County, TW	4	10
# of filed Patents : 4 Total Citations : 10
Lin, Feng-Huei	Taoyuan County, TW	50	80
# of filed Patents : 50 Total Citations : 80
Liu, Chia-Ching	Taoyuan County, TW	4	9
# of filed Patents : 4 Total Citations : 9
Tsai, Chin-Yan	Taoyuan County, TW	2	10
# of filed Patents : 2 Total Citations : 10

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 9 Citation Count
• G01N Class

• 13.80 % this patent is cited more than
• 11 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Apr 2, 2026

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2016/0130,259

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

---

Abstract

---

The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.